Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Telmisartan in patients with mild/moderate hypertension and chronic kidney disease.

Sharma AM, Hollander A, Köster J; Efficacy and Safety in Patients with Renal Impairment; treated with Telmisartan (ESPRIT) Study Group.

Clin Nephrol. 2005 Apr;63(4):250-7.

PMID:
15847251
2.

Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease.

Rysavá R, Tesar V, Merta M; Czech Group for the Study of Glomerulonephritis.

Blood Press Monit. 2005 Aug;10(4):207-13.

PMID:
16077267
4.

Assessment of efficacy, safety and tolerability of fixed dose combination of telmisartan 40mg and hydrochlorothiazide 12.5mg in adult Indian patients with mild to moderate hypertension.

Jayaram S, Lahoti S, Chandrasekharan S, Ganesan R, Muralidharan RS, Mishra AB, Sodhi SS, Rajadhyaksha GC, Jain SD, Kadam GS, Gawde A, Desai A.

J Indian Med Assoc. 2004 Sep;102(9):525-7.

PMID:
15887845
5.

Efficacy and safety of telmisartan vs. losartan in control of mild-to-moderate hypertension: a multicentre, randomised, double-blind study.

Zhu JR, Bai J, Cai NS, Tang B, Fan WH, Guo JZ, Ke YN, Guo JX, Sheng LH, Lu ZY, Cheng NN.

Int J Clin Pract Suppl. 2004 Dec;(145):46-9.

PMID:
15617459
8.

Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo.

Manolis AJ, Reid JL, de Zeeuw D, Murphy MB, Seewaldt-Becker E, Köster J; ARAMIS Study Group.

J Hypertens. 2004 May;22(5):1033-7.

PMID:
15097245
9.
10.

Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.

Neutel JM, Kolloch RE, Plouin PF, Meinicke TW, Schumacher H; OTELLOH Study Group.

J Hum Hypertens. 2003 Aug;17(8):569-75.

PMID:
12874615
11.

The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension.

Nalbantgil I, Nalbantgil S, Ozerkan F, Yilmaz H, Gürgün C, Zoghi M, Aytimur M, Onder R.

Int J Clin Pract Suppl. 2004 Dec;(145):50-4.

PMID:
15617460
12.

Clinical efficacy and safety of telmisartan 80 mg once daily vs. atenolol 50 mg once daily in patients with mild-to-moderate hypertension.

Alcocer L, Fernández-Bonetti P, Campos E, Olvera Ruiz R, Bahena J, de la Fuente JJ, Segovia-Ayala C, Dominguez-Henkel R.

Int J Clin Pract Suppl. 2004 Dec;(145):35-9.

PMID:
15617457
13.
14.
15.

Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial.

Zhu DL, Bays H, Gao P, Mattheus M, Voelker B, Ruilope LM.

Clin Ther. 2012 Jul;34(7):1613-24. doi: 10.1016/j.clinthera.2012.05.007. Epub 2012 Jun 19.

PMID:
22717420
16.
19.

Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study.

Freytag F, Schelling A, Meinicke T, Deichsel G; Telmisartan Hypertension Experience in a Randomized European Study Versus Atenolol Study Group.

Clin Ther. 2001 Jan;23(1):108-23.

PMID:
11219471
20.

Renoprotective effects of telmisartan in patients with advanced chronic kidney disease.

Tokunaga M, Kabashima N, Serino R, Shibata T, Matsumoto M, Miyamoto T, Miyazaki M, Furuno Y, Nakamata J, Fujimoto Y, Takeuchi M, Abe H, Okazaki M, Otsuji Y, Tamura M.

Clin Nephrol. 2010 Feb;73(2):139-46.

PMID:
20129021

Supplemental Content

Support Center